Stockholders' Equity (Deficiency) - Stock-Based Compensation Expense (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Stock-based compensation expense | $ 5,673,654 | $ 541,056 | $ 5,953,282 | $ 1,087,288 |
| Research and development | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Stock-based compensation expense | 157,291 | 232,154 | 221,968 | 438,740 |
| Selling, general and administrative | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Stock-based compensation expense | 5,516,363 | $ 308,902 | 5,731,314 | $ 648,548 |
| Selling, general and administrative | Inducement Awards | ||||
| Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
| Stock-based compensation expense | $ 5,190,000 | $ 5,190,000 | ||